ABSTRACT
Vaccinations in the elderly population
Given that the life expectancy has increased significantly, elderly people in the high-risk group should take special care of their health in terms of vaccinations against certain infectious diseases. According to the WHO recommendations, elderly people should be vaccinated on a regular basis against influenza as well as against other infectious diseases, which only recently have become vaccinable, due to the related risk of infection, e.g. against pneumococcal infections, hepatitis A and B, measles, mumps, rubella, tetanus, pertussis and diphtheria. Of the listed infectious diseases, influenza is considered a serious global health threat to the entire human population worldwide due to its antigenic variability. This includes in particular people aged over 65. In terms of the total mortality, influenza and pneumonia are ranked the 6th leading causes of death or the 5th in the elderly population. It is worth noting that complications of any infectious disease should be considered not only in terms of the general health impact but also in terms of the quantifiable costs of healthcare, which are borne by the country.
Piśmiennictwo
1. American Committee on Immunization Practices (ACIP). Prevention and Control of Influenza with vaccines: Recommendation of the Advisory Committee on Immunization Practices. MMWR 2018;49(No. RR-3):3-20
2. https://gis.gov.pl/zdrowi/szczepienia
3. Sheikh S, Biundo E, Courcier S, et al. A report on the status of vaccination in Europe. Vaccine 2018;36(33):4979-92
4. Brydak LB. Kliniczna charakterystyka grypy i powikłania pogrypowe. W: Grypa. Pandemia grypy: mit czy realne zagrożenie? Warszawa: Wydawnictwo Rytm 2008:101-24
5. Brydak LB. Skutki zdrowotne i ekonomiczne zakażeń grypą w aspekcie zdrowia publicznego w Polsce. W: Nowakowska E (red.). Farmakoekonomika w zarządzaniu zasobami ochrony zdrowia. Warszawa: Wolters Kluwer 2018:274-83
6. https://www.who.int/influenza/global_influenza_strategy_2019_2030/en/
7. http://www.pzh.gov.pl/oldpage/epidemiol/grypa/index
8. American Committee on Immunization Practices (ACIP). Prevention and Control of Influenza with vaccines: Recommendation of the Advisory Committee on Immunization Practices. MMWR 2010;49(No. RR-3):3-20
9. Smetana J, Chlibek R, Shaw J, et al. Influenza vaccination in the elderly. HumVaccin Immmunother 2018;14(3):540-9
10. https://stat.gov.pl/obszary-tematyczne/ludnosc/ludnosc/ludnosc-stan-i-struktura-oraz- ruch-naturalny-w-przekroju-terytorialnym-w-2018-r-stan-w-dniu-31-xii,6,25.html
11. Bilińska ZT, Brydak LB. Powikłania sercowo-naczyniowe grypy. Kardiol Pol 2003;59(11):431-5
12. Ciszewski S, Bilińska ZT, Brydak LB, et al. Influenza vaccination in prevention from coronary ischemic events, coronary artery disease: FLUCAC study. European Heart Journal 2008;29:2909-45
13. Lavallee PH, Perchaud V, Gautier-Bertrand M, et al. Association between influenza vaccination and reduced risk of brain infraction. Stroke 2002;33:513-18
14. Baker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implication for preventing. Arch Intern Mrs 1982;142:85-89
15. Louria PB, Blumenfeld HL, Ellis IT, et al. Studies on influenza in the pandemic of 1957-1958. Pulmonary complications of influenza. J Clin Invest 1968;38:213-65
16. Brydak LB. Grypa – problem zdrowia publicznego. Praktyka Lekarska. Zeszyty specjalne 2007/2008;1-9
17. Newall AT, Dehollain JP. The cost-effectiveness of influenza vaccination in elderly Australians exploratory analysis of the vaccine efficacy required. Vaccine 2014:32(12):1323-5
18. Maciosek MV, Solberg L, Coffield AB, et al. Influenza vaccination impact and cost effectiveness among adults aged 50 to 64 and 65 and older. Am J Prev Med 2006;31(1):72-79
19. Brydak LB. Profilaktyka i skutki ekonomiczne grypy. W: Grypa. Pandemia grypy: mit czy realne zagrożenie? Warszawa: Wydawnictwo Rytm 2008:364-418
20. Health at a Glance. Influenza vaccination rates – OECD Data, 2017. https://data oecd.org/healthcare/influenza-vaccination-rates.htm
